<?xml version="1.0"?>
<trials subjects="1">
  <Triall>
    <main>
      <UTRN />
      <trial_id>ChiCTR-TRC-08000080</trial_id>
      <utrn />
      <reg_name>ChiCTR</reg_name>
      <date_registration>2008-04-10</date_registration>
      <primary_sponsor>Navy general hospital of China liberation army</primary_sponsor>
      <public_title>Efficacy and safety of Mesenchymal stem cell injection for the treatment of acute myocardial infarction: a single blinding, muticenter randomized control trial.</public_title>
      <acronym />
      <scientific_title>Efficacy and safety of Mesenchymal stem cell injection for the treatment of acute myocardial infarction: a single blinding, muticenter randomized control trial.</scientific_title>
      <Scientific_acronym />
      <date_enrolment>2008-01-01</date_enrolment>
      <type_enrolment />
      <target_size>Group A:120;Group B:120;</target_size>
      <recruitment_status>Completed</recruitment_status>
      <url>http://www.chictr.org.cn/showproj.aspx?proj=9445</url>
      <study_type>Interventional study</study_type>
      <study_design>Randomized parallel controlled trial</study_design>
      <phase>Pilot study</phase>
      <hc_freetext>ST-elevated acute myocardial infarction (ST-AMI)</hc_freetext>
      <i_freetext>Group A:Routine therapy as Guideline recommended+ PCI;Group B:Routine therapy as Guideline recommended+ PCI+transplantation of (MSCs);</i_freetext>
      <results_actual_enrolment />
      <results_date_completed />
      <results_url_link />
      <results_summary />
      <results_date_posted />
      <results_date_first_publication />
      <results_baseline_char />
      <results_participant_flow />
      <results_adverse_events />
      <results_outcome_measures />
      <results_url_protocol />
      <results_IPD_plan />
      <results_IPD_description />
    </main>
    <contacts>
      <contact>
        <type>Scientific</type>
        <firstname>Yu Chen</firstname>
        <middlename />
        <lastname />
        <address>Cardiovascular department of Navy general hospital of China liberation army; 6 Hucheng Road, Haidian District, Bejing</address>
        <city />
        <country1 />
        <zip>100037</zip>
        <telephone>+86 0 13381207390</telephone>
        <email>yuchen911@hotmail.com</email>
        <affiliation>Navy general hospital of China liberation army</affiliation>
      </contact>
      <contact>
        <type>Public</type>
        <firstname>Lianru Gao</firstname>
        <middlename />
        <lastname />
        <address>6 Hucheng Road, Haidian District, Bejing</address>
        <city />
        <country1 />
        <zip>100037</zip>
        <telephone>+86 0 13381207121</telephone>
        <email>lianru@yahoo.com.cn</email>
        <affiliation />
      </contact>
    </contacts>
    <countries>
      <country2>China</country2>
    </countries>
    <criteria>
      <inclusion_criteria>1. Diagnosis is ST-elevated acute myocardial infarction based by WHO standard;
2. Less than 1 month since the onset of ST-AMI;
3. Successfully vessel reconstructed and TIMI&gt;3;
4. Age&gt;18 years old;
5. Patients who sign informed consent form and can finish whole follow-up.</inclusion_criteria>
      <agemin>18</agemin>
      <agemax />
      <gender>Both</gender>
      <exclusion_criteria>1. Patients who are complicated with other heart disease, including:
Refractory sustained ventricle tachycardia;
Severe heart block and not controlled by heart pace maker;
Genetic heart disease;
Primary heart valve disease;
Active myocarditis;
Pulmonary heart disease, etc.;
2. Liver or kidney dysfunction (ALT&gt;80U/L, Cr&gt;440mmol/L);
3. Patients with autoimmune disease or any other severe fatality disease;
4. Patients have contradictions of percutaneous coronary intervention;
5. Patients with psychiatric disease.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code />
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword />
    </health_condition_keyword>
    <intervention_code>
      <i_code>;;</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword />
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Left ventricle ejective fraction;Change of myocardial metabolis;</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome>Mortality;Incidence of cardiovascular event;</sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name />
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id />
        <issuing_authority />
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>National High Technology Research and Development Program of China (863 Program)</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2007-11-02</approval_date>
        <contact_name />
        <contact_address />
        <contact_phone />
        <contact_email />
      </ethics_review>
    </ethics_reviews>
  </Triall>
</trials>